Novartis | NOVN - Debt

Stock Price
119.96
Daily Change
0.68 0.57%
Monthly
5.60%
Yearly
23.89%
Q1 Forecast
111.83

Novartis reported $32.64B in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alcon AG USD 5.25B 57M Jun/2025
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Autolus Therapeutics Ltd USD 253.44M 8.84M Mar/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Fresenius EUR 12.85B 778M Jun/2025
Fresenius Medical Care EUR 11.02B 203.55M Jun/2025
Galapagos EUR 10.86M 864K Mar/2025
Genmab DKK 148M 5M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 9.4B 704M Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novartis USD 32.02B 615M Sep/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Orion EUR 321.2M 6M Mar/2025
Pfizer USD 60.85B 78M Sep/2025
Philips EUR 8.43B 857M Jun/2025
Recordati EUR 2.47B 112.82M Jun/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024